| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/24/1997 | WO1997014438A1 Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist |
| 04/24/1997 | WO1997014437A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | WO1997014427A1 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b |
| 04/24/1997 | WO1997014414A1 Use of nitroflavonoids for the treatment of anxiety |
| 04/24/1997 | WO1997009348A3 Orphan receptor |
| 04/24/1997 | DE19540475A1 Chirale Methylphenyloxazolidinone Chiral methylphenyloxazolidinones |
| 04/24/1997 | CA2235278A1 Use of protein s-100b in medicines and medicines containing the protein s-100b |
| 04/24/1997 | CA2233848A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | CA2229710A1 Amino substituted pyrimidines and triazines |
| 04/23/1997 | EP0769297A1 Use of nefazodone for the manufacture of a medicament for the treatment of panic attack |
| 04/23/1997 | EP0769006A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/23/1997 | EP0768883A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 04/23/1997 | EP0670825B1 Nitric esters having a pharmacological activity and process for their preparation |
| 04/23/1997 | EP0651754B1 K-252a DERIVATIVES |
| 04/23/1997 | EP0626942B1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 04/23/1997 | CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines |
| 04/23/1997 | CN1148337A Compound active at a novel site on receptor-operated calcium channels usefull for treatment of neurological disorders and diseases |
| 04/22/1997 | US5622990 Dry, roller compacted powder comprising low amount excipients, free of disintegrant |
| 04/22/1997 | US5622976 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 04/22/1997 | US5622970 Controlling graft rejection |
| 04/22/1997 | US5622968 Acenaphthyl substituted guanidines and methods of use thereof |
| 04/22/1997 | US5622965 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
| 04/22/1997 | US5622957 Inducers of tyrosine hydroxylase; treatment of depression and anxiety |
| 04/22/1997 | US5622952 Glycine receptor antagonists and the use thereof |
| 04/22/1997 | US5622948 Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
| 04/22/1997 | US5622928 Glia activation factor and its production |
| 04/22/1997 | US5622722 Mixture of water soluble active drug, microcrystalline cellulose and sugar |
| 04/22/1997 | US5622704 Anxiolytic |
| 04/18/1997 | CA2187989A1 Nefazodone: treatment of panic attack |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013770A1 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use |
| 04/17/1997 | WO1997013769A1 Disubstituted piperidine derivatives |
| 04/17/1997 | WO1997013768A1 Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof |
| 04/17/1997 | WO1997013759A1 Pyrimidin derivatives |
| 04/17/1997 | WO1997013754A1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof |
| 04/17/1997 | WO1997013514A1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 04/17/1997 | WO1997013512A1 N-[2-substituted-3-(2-aminoethyl)-1h-indol-5-yl]-amides: new 5-ht1f agonists |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013504A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/17/1997 | WO1997013489A2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2234166A1 N-¬2-substituted-3-(2-aminoethyl)-1h-indol-5-yl|-amides: new 5-ht1f agonists |
| 04/17/1997 | CA2233673A1 Disubstituted piperidine derivatives |
| 04/17/1997 | CA2233502A1 Pyrimidin derivatives |
| 04/17/1997 | CA2206446A1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof |
| 04/16/1997 | EP0768312A2 Bis-Staurosporine and K-252a derivatives |
| 04/16/1997 | EP0768310A1 Process for the production of imidazo-benzodiazepine derivatives |
| 04/16/1997 | EP0768307A1 Heterocyclic tertiary amines, process for their preparation and pharmaceutical compositions containing them |
| 04/16/1997 | EP0768301A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists |
| 04/16/1997 | EP0768087A2 Treating substance abuse withdrawal |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767793A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 04/16/1997 | EP0767782A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 04/16/1997 | EP0767675A1 The use of cross-linked hemoglobin in treating subarachnoid hemorrhage |
| 04/16/1997 | EP0767674A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 04/16/1997 | EP0767672A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis |
| 04/16/1997 | EP0767669A1 New pharmaceutical preparation for pain management |
| 04/16/1997 | EP0767663A1 Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 04/16/1997 | EP0767661A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 04/16/1997 | EP0767659A1 Transdermal administration of oxybutynin |
| 04/16/1997 | EP0767634A1 Microcapsules for administration of neuroactive agents |
| 04/16/1997 | EP0701551B1 3-(indol-3-yl) propenoic acid derivatives useful as nmda antagonists |
| 04/16/1997 | EP0586525B1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives |
| 04/16/1997 | CN1147819A New opioid peptide analogs with mixed MU agonist/delta antagonist properties |
| 04/16/1997 | CN1147815A Adenosine derivatives |
| 04/16/1997 | CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia |
| 04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/16/1997 | CN1034575C Producing process for selective adenosine receptor agents |
| 04/16/1997 | CN1034552C Preparation of decahydro-isoquinoline derivatives |
| 04/15/1997 | US5621114 Reacting a thio or phenol compound with 1,1-carbonylimidazole or 1,1-thiocarbonyldiimidazole, reacting the intermediate with secondary amine compound; useful as analgesic and memory enhancing agent |
| 04/15/1997 | US5621113 4-[(thien-2-yl)methyl]-imidazole analgesics |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621011 [α-tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses |
| 04/15/1997 | US5621000 Nitric esters having a pharmacological activity and process for their preparation |
| 04/15/1997 | US5620992 Having 5-hydroxytryptamine receptor antagonist activity |
| 04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620988 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620979 Treating neuronal loss associated with stroke, ischemia, central nervous system trauma, hypoglycemia or surgery |
| 04/15/1997 | US5620978 Nervous system disorders |
| 04/15/1997 | US5620976 Benzoxazine derivatives |
| 04/15/1997 | US5620966 11,21-bisphenyl-19-norpregnane derivatives |
| 04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/15/1997 | US5620701 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 04/15/1997 | CA2104229C Opiate receptor antagonist modulates movement disorder |
| 04/15/1997 | CA2006398C Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof |
| 04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012880A1 Pyrimidine derivatives as 5ht2c-receptor antagonists |
| 04/10/1997 | WO1997012874A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012634A1 A NOVEL COMBINATION OF A β-RECEPTOR BLOCKER AND AN OPIOID |
| 04/10/1997 | WO1997012605A1 Controlled release matrix for pharmaceuticals |
| 04/10/1997 | WO1997012583A2 Stable compositions containing n-propargyl-1-aminoindan |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233003A1 Pyrimidine derivatives as 5ht2c-receptor antagonists |